Investors

Key press releases

Key upcoming events

Key corporate presentation

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

Cellectis ADS (Nasdaq)

Ticker: CLLS

$14.7261

+0.1661 (1.1408%)

Prev. close
14.5600
Volume
53,493
High
14.8600
Capitalization
625.059M
Last Update: 36 minutes ago

Cellectis (Euronext Growth Paris)

Ticker: ALCLS

€13.3600

+0.2400 (1.8293%)

Prev. close
13.1200
Volume
15,251
High
13.4000
Capitalization
567.074M
Last Update: 3 hours ago

Covering research analysts

Barclays - Gena Wang

Bryan Garnier – Marion Levi

BTIG - Amanda Murphy

Citi - Yigal Nochomovitz

Goldman Sachs - Salveen Richter

Guggenheim - Michael Schmidt

Jefferies – Biren Amin

Jones Trading - Soumit Roy

Ladenburg – Wangzhi Li

Nomura / Instinet – Christopher Marai

Oddo BHF - Martial Descoutures

Oppenheimer – Hartaj Singh

Portzamparc – Christophe Dombu

Wells Fargo – Jim Birchenough

William Blair – Raju Prasad

Cellectis contact information

Simon Harnest
Investor Relations USA
+1 646 385 9008

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89